4 results on '"Bottani, G"'
Search Results
2. [Antazoline: the preferred drug for therapy of extra-systolic arrhythmia during anesthesia].
- Author
-
Bottani G, Allaria B, Castelli S, and Ferraris E
- Subjects
- Adult, Aged, Arrhythmias, Cardiac etiology, Electrocardiography, Female, Humans, Male, Middle Aged, Anesthesia adverse effects, Anti-Arrhythmia Agents therapeutic use, Arrhythmias, Cardiac drug therapy, Imidazoles therapeutic use
- Published
- 1968
3. Hernia repair in the Lombardy region in 2000: preliminary results
- Author
-
Ferrante, F., Rusconi, A., Galimberti, A., Grassi, M., Beluffi, L., Salamina, G., Casati, A., Cassinelli, G. B., Colpani, L., Colledan, M., Forloni, B., Geroni, P., Longoni, M., Morelli, A., Novelino, L., ENRICO OPOCHER, Pecis, C., Perrone, G., Baroni, C., Capretti, P. L., Cazzaniga, R., Giovannetti, M., Puccio, F., Marcianò, P., Sbarbada, V., Scheda Ricciotti, G., Tambussi, U., Zola, C., Formenti, A., Rumi, A., Savio, S., Tommasini Degna, C., Alquati, P., Brown, P., Gafà, M., Martinotti, A., Costa, M., Confalonieri, G. M., Crema, G., Erba, R., Frega, G., Olivari, N., Pricolo, R., Benati, L., Campo, S., Mariani, G., Bruni, T., Fontanili, M., Arisi, G. P., Beltramo, M., Bocca, M., Bragherio, G., Brambilla, A., Cacioli, D., Calzoni, D., Magnoni, E., Castoldi, M., Ceriani, V., Ballabio, R., Confalonieri, F., Contessini Avesani, E., Campanelli, G. P., Trivellini, G., Corsi, C., Croce, E., Creperio, G., Di Carlo, V., Familiari, G., Ferla, F., Ferrari, G., Forti, D., Greco, D., Fox, U., Gherardi, G., Lunghi, C., Maggioni, P., Mantovani, G., Maruotti, R., Mascia, G., Mentasti, A., Mezzeti, M., Monestiroli, U., Nespoli, A., Potestio, M., Rolandi, P., Rosati, R., Roviaro, G. C., Sampietro, R., Scorza, R., Staudacher, C., Stefanoni, G., Taschieri, A., Tenchini, P., Trabattoni, P., Trabucchi, E., Uggeri, F., Bottani, G., Cebrelli, C., Fossati, G., Ferrante, F, Rusconi, A, Galimberti, A, Grassi, M, Beluffi, L, Salamina, G, Casati, A, Cassinelli, G, Colpani, L, Colledan, M, Forloni, B, Geroni, P, Longoni, M, Morelli, A, Novelino, L, Opocher, E, Pecis, C, Perrone, G, Baroni, C, Capretti, P, Cazzaniga, R, Giovannetti, M, Puccio, F, Marciano, P, Sbarbada, V, Scheda Ricciotti, G, Tambussi, U, Zola, C, Formenti, A, Rumi, A, Savio, S, Tommasini Degna, C, Alquati, P, Brown, P, Gafa, M, Martinotti, A, Costa, M, Confalonieri, G, Crema, G, Erba, R, Frega, G, Olivari, N, Pricolo, R, Benati, L, Campo, S, Mariani, G, Bruni, T, Fontanili, M, Arisi, G, Beltramo, M, Bocca, M, Bragherio, G, Brambilla, A, Cacioli, D, Calzoni, D, Magnoni, E, Castoldi, M, Ceriani, V, Ballabio, R, Confalonieri, F, Contessini Avesani, E, Campanelli, G, Trivellini, G, Corsi, C, Croce, E, Creperio, G, Di Carlo, V, Familiari, G, Ferla, F, Ferrari, G, Forti, D, Greco, D, Fox, U, Gherardi, G, Lunghi, C, Maggioni, P, Mantovani, G, Maruotti, R, Mascia, G, Mentasti, A, Mezzeti, M, Monestiroli, U, Nespoli, A, Potestio, M, Rolandi, P, Rosati, R, Roviaro, G, Sampietro, R, Scorza, R, Staudacher, C, Stefanoni, G, Taschieri, A, Tenchini, P, Trabattoni, P, Trabucchi, E, Uggeri, F, Bottani, G, Cebrelli, C, and Fossati, G
- Subjects
Male ,Reoperation ,medicine.medical_specialty ,Hernia ,medicine.medical_treatment ,Risk Assessment ,Severity of Illness Index ,Postoperative Complications ,Recurrence ,Surveys and Questionnaires ,medicine ,Humans ,Anesthesia ,Herniorrhaphy ,Surgical repair ,Mesh ,Recurrent Inguinal Hernia ,Hospital stay ,Laparotomy ,Surgical approach ,business.industry ,General surgery ,Surgical Mesh ,medicine.disease ,Hernia repair ,Surgery ,Treatment Outcome ,Female ,Follow-Up Studies ,Health Care Surveys ,Italy ,Laparoscopy ,Anterior approach ,business ,Abdominal surgery - Abstract
Hernia repair is the most common surgical procedure in general surgery in Italy and in the Lombardy region. In the last decade, the use of mesh, the concept of a tension-free technique, and the postoperative rate of recurrences after Bassini or Shouldice operations have completely changed the surgical approach to hernia repair. For this reason, we sent a questionnaire to 148 surgical departments in the Lombardy region to investigate about total hernia operations performed in 2000 in Lombardy, the surgical approach, the surgical techniques used, the type of anesthesia and the hospital stay. One hundred five out of 148 surgical departments returned the questionnaire, and we collected information on a total of 16,935 surgical operations for hernia: 16,494 were performed using tension-free techniques. The inguinal anterior approach is the one of choice for primary and recurrent inguinal hernia, whereas the open preperitoneal and laparoscopic approaches are limited to bilateral and recurrent hernias. The majority of cases were treated under locoregional anesthesia and with a hospital stay of two nights.
- Published
- 2002
4. PROPHYLAXIS OF VENOUS THROMBOEMBOLISM WITH LOW MOLECULAR WEIGHT HEPARIN IN BARIATRIC SURGERY: A PROSPECTIVE, RANDOMISED PILOT STUDY EVALUATING TWO DOSES OF PARNAPARIN (BAFLUX STUDY)
- Author
-
Esmeralda Filippucci, Stefano Cariani, Edoardo Baldini, Marco De Paoli, Giorgio Bottani, Davide Imberti, Matteo Giorgi Pierfranceschi, Alberto Nicolini, Concetto Cartelli, Marcello Boni, Imberti, D, Baldini, E, Pierfranceschi, MG, Nicolini, A, Cartelli, C, De Paoli, M, Boni, M, Filippucci, E, Cariani, S, and Bottani, G
- Subjects
Adult ,Male ,medicine.medical_specialty ,medicine.drug_class ,Endocrinology, Diabetes and Metabolism ,Original Contributions ,Premedication ,Treatment outcome ,Low molecular weight heparin ,Pilot Projects ,Drug Administration Schedule ,medicine ,Humans ,Prospective Studies ,Obesity ,Prophylaxi ,Prospective cohort study ,Bariatric surgery ,Nutrition and Dietetics ,Dose-Response Relationship, Drug ,business.industry ,Prophylaxis ,Anticoagulants ,Heparin, Low-Molecular-Weight ,Surgery ,Obesity, Morbid ,Heparin.low molecular weight ,Treatment Outcome ,Anesthesia ,Parnaparin ,Female ,business ,Venous thromboembolism - Abstract
Background: The optimal dose of low molecular weight heparin (LMWH) to prevent venous thromboembolism (VTE) after bariatric surgery remains controversial. The aim of this multicentre, open-label, pilot study was to evaluate the efficacy and safety of two different doses of the LMWH parnaparin administered to patients undergoing bariatric surgery. Methods: Patients were randomised to receive 4,250 IU/day (group A) or 6,400 IU/day (group B) of parnaparin s.c. for 7-11 days. Bilateral colour Doppler ultrasound of the lower limb was performed before surgery and at the end of the treatment period. The primary efficacy outcome was a composite of asymptomatic and symptomatic deep vein thrombosis, symptomatic pulmonary embolism and death from any cause during treatment. The primary safety endpoint was major and clinically relevant non-major bleeding. Results: A total of 258 patients underwent randomization; 8 subjects were excluded following the safety analysis. One hundred thirty-one patients [106 females; mean age, 40.3 years (standard deviation (SD) ±9.6); mean body mass index (BMI), 44.6 kg/m2 (SD ±5.4)] were assigned to group A and 119 patients [93 females; mean age, 41.5 years (SD ±9.9); mean BMI, 44.2 kg/m2 (SD ±5.4)] were assigned to group B. The rate of the primary efficacy outcome was 1.5 % (two cases; 95 % confidence interval (CI), 0.2-6.0 %) in group A as compared with 0.8 % (one case; 95 % CI, 0.4-5.3 %) in group B (p = ns). The composite incidence of major bleeding and clinically relevant non-major bleeding was 6.1 % (eight cases; 95 % CI, 2.9-12.1 %) in group A and 5.0 % (six cases; 95 % CI, 2.1-11.1 %) in group B (p = ns). Conclusions: A parnaparin dose of 4,250 IU/day seems suitable for VTE prevention in patients undergoing bariatric surgery. © 2013 The Author(s).
- Published
- 2014
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.